Insights

Innovative Adhesive Technology RevBio's TETRANITE platform offers a unique, patent-protected bone adhesive with superior performance in rapid fixation, wet-field adhesion, and biodegradability. This technological edge provides a compelling value proposition for hospitals and surgical centers seeking advanced, minimally invasive solutions for musculoskeletal repairs.

Expanding Clinical Validation With multiple FDA-approved clinical trials and recent NIH grants totaling over $4.8 million, RevBio is validating the safety and efficacy of its bone adhesive. This strong clinical evidence supports credibility and accelerates adoption potential within orthopedic, neurosurgical, and dental markets.

Market Growth Potential Targeting a total addressable market exceeding $10 billion across various segments, RevBio's innovative adhesive is positioned to disrupt traditional hardware-based treatments. Opportunities exist to engage hospitals, surgical centers, and implant manufacturers looking for more effective, less invasive bone healing solutions.

Strategic Partnerships Partnerships with research institutions like the University of Pittsburgh and clinical collaborators such as Semmes Murphey demonstrate a proactive approach to validation and market entry. Collaborating with key medical leaders can enhance credibility and facilitate product adoption in targeted treatment areas.

Funding and Support Recent NIH grants of over $2.4 million highlight strong institutional backing and validation of RevBio’s technology. Leveraging this funding to expand clinical trials and regulatory pathways can open pathways for sales growth and regulatory approval in new indications and markets.

RevBio, Inc. Tech Stack

RevBio, Inc. uses 8 technology products and services including Shopify, Element UI, Swiper, and more. Explore RevBio, Inc.'s tech stack below.

  • Shopify
    E-commerce
  • Element UI
    Javascript Frameworks
  • Swiper
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • Yoast SEO
    Search Engines
  • GoDaddy
    Web Hosting
  • Kadence WP Blocks
    Web Platform Extensions
  • Nginx
    Web Servers

RevBio, Inc.'s Email Address Formats

RevBio, Inc. uses at least 2 format(s):
RevBio, Inc. Email FormatsExamplePercentage
FLast@launchpadmedical.comJDoe@launchpadmedical.com
76%
LFirst@launchpadmedical.comDJohn@launchpadmedical.com
10%
Last@launchpadmedical.comDoe@launchpadmedical.com
9%
First.Last@launchpadmedical.comJohn.Doe@launchpadmedical.com
5%
FLast@revbio.comJDoe@revbio.com
70%
Last@revbio.comDoe@revbio.com
30%

Frequently Asked Questions

Where is RevBio, Inc.'s headquarters located?

Minus sign iconPlus sign icon
RevBio, Inc.'s main headquarters is located at 600 Suffolk Street Suite 250 Lowell, Massachusetts 01854 United States. The company has employees across 1 continents, including North America.

What is RevBio, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact RevBio, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is RevBio, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
RevBio, Inc.'s official website is revbio.com and has social profiles on LinkedInCrunchbase.

What is RevBio, Inc.'s NAICS code?

Minus sign iconPlus sign icon
RevBio, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does RevBio, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, RevBio, Inc. has approximately 34 employees across 1 continents, including North America. Key team members include Ceo And Founder: B. H.Cfo/Coo & Co-Founder: D. G. A.Chief Marketing Officer: M. T.. Explore RevBio, Inc.'s employee directory with LeadIQ.

What industry does RevBio, Inc. belong to?

Minus sign iconPlus sign icon
RevBio, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does RevBio, Inc. use?

Minus sign iconPlus sign icon
RevBio, Inc.'s tech stack includes ShopifyElement UISwiperHubSpotYoast SEOGoDaddyKadence WP BlocksNginx.

What is RevBio, Inc.'s email format?

Minus sign iconPlus sign icon
RevBio, Inc.'s email format typically follows the pattern of FLast@launchpadmedical.com. Find more RevBio, Inc. email formats with LeadIQ.

How much funding has RevBio, Inc. raised to date?

Minus sign iconPlus sign icon
As of April 2026, RevBio, Inc. has raised $2.4M in funding. The last funding round occurred on Sep 16, 2024 for $2.4M.

When was RevBio, Inc. founded?

Minus sign iconPlus sign icon
RevBio, Inc. was founded in 2014.

RevBio, Inc.

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

The standard of care for healing broken bones hasn't changed in over fifty years. Invasive metal hardware is still routinely used to fixate bones–often with less-than-optimal patient outcomes. RevBio® is a medical device company that has invented TETRANITE®, a regenerative bone adhesive currently in 150 patients across seven FDA approved clinical trials. Our patented “bone glue” is founded upon a comprehensive patent portfolio with global patent protection extending through 2042. Easily injectable into a range of musculoskeletal defects, TETRANITE has demonstrated superior performance over other standard of care options in curing speed and strength, rate of resorption, bone regeneration, and most critically wet-field adhesion. As a novel technology, TETRANITE is anticipated to receive a De Novo classification for several indications which will expedite the path to commercialization by Q3 2027. Bioengineered for a body of applications, the TETRANITE platform will address a total addressable market of over $10 billion in neurosurgical, orthopaedic and dental use cases.Inspired by the marine animal the sandcastle worm, Tetranite is simple chemistry. Bioengineered from the worm’s secreted protein, our synthetic adhesive is the only patented biomaterial which satisfies both the required and desired properties for a bone adhesive: wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability.

The properties of Tetranite™ include the ability to provide immediate fixation of bone to bone and bone to metal. This adhesive has been shown in multiple animal studies to be a non-toxic and effective way of repairing bone fractures and defects as well as securing implant devices.  Existing data has also shown that Tetranite™ is reabsorbed and replaced with new bone during the natural process of bone remodeling by acting as a scaffold to facilitate bone growth over time.

Section iconCompany Overview

Headquarters
600 Suffolk Street Suite 250 Lowell, Massachusetts 01854 United States
Phone number
Website
revbio.com
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $2.4M

    RevBio, Inc. has raised a total of $2.4M of funding over 21 rounds. Their latest funding round was raised on Sep 16, 2024 in the amount of $2.4M.

Section iconFunding & Financials

  • $2.4M

    RevBio, Inc. has raised a total of $2.4M of funding over 21 rounds. Their latest funding round was raised on Sep 16, 2024 in the amount of $2.4M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.